Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Check out this updated Notice of Special Interest if you’re interested in supplemental funds for activities that will make NIH-supported data usable for artificial intelligence and machine learning analytics!

Discover how the algorithms produced in this challenge performed in detecting breast cancer.

Are you working on software tools to promote open science in cancer research? NCI has issued a Notice of Special Interest offering supplemental funding for work in this area. The application due date is May 9, 2023.

Planning your itinerary for this year’s American Association for Cancer Research (AACR) Annual Meeting? Want to make sure you catch the NCI-affiliated data science activities? We’ve put together a helpful reference page for you!

Apply by April 11 for administrative supplemental funding to explore and test new opportunities for leveraging cloud-based solutions for NIH-funded research.

NIH wants to hear from you about the NIH Public Access Plan, which shows how to accelerate access to federally supported scientific data and research.

NCI-funded researchers combined long-term, patient-outcome data with pathology slides from people with colorectal cancer to develop a machine learning tool, called QuantCRC. Using QuantCRC, researchers could predict if a patient’s cancer would recur based on analysis of a single hematoxylin and eosin stained slide of the tumor.

See if any of the available grants highlighted in this Notice of Special Interest are a good fit for your data science work.

Learn more about this job opportunity to head the Biostatistics and Data Management Section of NCI’s Center for Cancer Research. The first review of applications will begin on March 13, 2023.

A new, NCI-funded, deep learning technology performed on par with radiologists in interpreting breast cancer images. This tool could help refine diagnosis to reduce the number of unnecessary biopsies.